XML 29 R16.htm IDEA: XBRL DOCUMENT v3.24.3
Other Balance Sheet Components
 9 Months Ended
Sep. 30, 2024
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Other Balance Sheet Components
9. Other Balance Sheet Components

Accounts Receivable, net

Accounts receivable, net, as of September 30, 2024 and December 31, 2023 consisted of the following (in millions):
September 30,December 31,
20242023
Accounts receivable$2,732 $1,584 
Less: Wholesalers chargebacks, discounts and fees
(1,168)(692)
Accounts receivable, net$1,564 $892 
Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets, as of September 30, 2024 and December 31, 2023 consisted of the following (in millions):
September 30,December 31,
20242023
Prepaid services$286 $182 
Down payments and prepayments related to manufacturing and materials
193 168 
Income tax receivable105 19 
Collaboration receivable99 61 
Interest receivable50 59 
Prepaid income tax
26 — 
Value added tax receivable18 50 
Other current assets46 88 
Prepaid expenses and other current assets$823 $627 

Other Non-Current Assets

Other non-current assets, as of September 30, 2024 and December 31, 2023 consisted of the following (in millions):
September 30,December 31,
20242023
Down payments and prepayments, non-current
$355 $342 
Inventory, non-current(1)
65 170 
Goodwill
52 52 
Finite-lived intangible asset
41 44 
Equity investments23 66 
Other20 11 
Other non-current assets$556 $685 
_______
(1)Consisted of raw materials with an anticipated consumption beyond one year.
Accrued Liabilities

Accrued liabilities, as of September 30, 2024 and December 31, 2023 consisted of the following (in millions):
September 30,December 31,
20242023
Provisions related to product sales (Note 3)
$403 $556 
Compensation-related244 245 
Other external goods and services177 137 
Manufacturing137 167 
Royalties92 122 
Development operations80 140 
Property, plant and equipment78 94 
Raw materials57 27 
Clinical trials51 175 
Commercial
36 56 
Loss on future firm purchase commitments(1)
21 79 
Accrued liabilities$1,376 $1,798 
______
(1)Related to losses that are expected to arise from firm, non-cancellable, commitments for future raw material purchases (Note 7).

Other Current Liabilities

Other current liabilities, as of September 30, 2024 and December 31, 2023 consisted of the following (in millions):
September 30,December 31,
20242023
Lease liabilities - financing (Note 10)
$30 $— 
Lease liabilities - operating (Note 10)
$21 $25 
Other18 41 
Other current liabilities$69 $66 

Other Non-Current Liabilities

Other non-current liabilities, as of September 30, 2024 and December 31, 2023 consisted of the following (in millions):
September 30,December 31,
20242023
Tax liabilities
$241 $235 
Other
35 21 
Other non-current liabilities
$276 $256 
Deferred Revenue

The following table summarizes the activities in deferred revenue for the nine months ended September 30, 2024 (in millions):
December 31, 2023AdditionsDeductionsSeptember 30, 2024
Product sales$613 $224 $(394)$443 
Grant revenue4 8 (1)11 
Collaboration revenue34 7 (34)7 
Licensing and royalty revenue
— 20 (7)13 
Total deferred revenue$651 $259 $(436)$474